Lost my dad to cancer. Would love to see these trials continue successfully
Twitter
Note: AI-generated summary based on third-party content. Not financial advice. Read more.
Quick Insights
MRNA is up over 70% following a positive Phase 3 result for a personalized cancer vaccine. The treatment, when combined with KEYTRUDA, successfully reduced the risk of melanoma returning or spreading.
Ask about this postAnswers are grounded in this post's content.
Tweet
About Austin Lieberman
Austin Lieberman
By LiebermanAustin
I write about high-quality stocks with 10x return potential. My latest portfolio update: https://t.co/WVRXiHv94q